Zhengye Biotechnology Holding (ZYBT) Goodwill & Intangibles (2023 - 2025)
Zhengye Biotechnology Holding (ZYBT) posted quarterly Goodwill & Intangibles of $14.5 million for Q4 2025, up 57.34% year-on-year from $9.2 million in Q4 2024, and up 582.33% on a QoQ basis from $2.1 million in Q2 2025.
Zhengye Biotechnology Holding (ZYBT) Goodwill & Intangibles (2023 - 2025) Analysis & Trends
Zhengye Biotechnology Holding (ZYBT) has reported Goodwill & Intangibles for 3 consecutive years, with $14.5 million the latest figure, recorded in Q4 2025.
- Quarterly Goodwill & Intangibles rose 57.34% year-over-year to $14.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $14.5 million (up 57.34% YoY) and the FY2025 annual result came in at $14.5 million, up 59.91% from the prior year.
- Goodwill & Intangibles advanced to $14.5 million in Q4 2025 per ZYBT's latest filing, from $2.1 million in the prior quarter.
- Over the last five years, Goodwill & Intangibles for ZYBT reached as high as $14.5 million in Q4 2025 and fell as low as $2.1 million in Q2 2025.
- A 3-year average of $8.7 million and a median of $9.1 million in 2023 frame the typical range for Goodwill & Intangibles.
- Annual changes were most pronounced in 2024 — Goodwill & Intangibles climbed 3.37% — and 2025, when it surged 57.34%.
- Year by year, Goodwill & Intangibles stood at $8.9 million in 2023, then advanced by 3.37% to $9.2 million in 2024, then jumped by 57.34% to $14.5 million in 2025.
- According to Business Quant data, Goodwill & Intangibles over the past three periods registered $14.5 million, $2.1 million, and $9.2 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Zhengye Biotechnology Holding | 85.23 Mn | 85.93 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 14.50 Mn |
| Jun 30, 2025 | 2.12 Mn |
| Dec 31, 2024 | 9.21 Mn |
| Dec 31, 2023 | 8.91 Mn |